$0.97 EPS Expected for Encompass Health Corp (NYSE:EHC) This Quarter

Equities analysts expect that Encompass Health Corp (NYSE:EHC) will announce $0.97 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Encompass Health’s earnings. The highest EPS estimate is $1.00 and the lowest is $0.95. Encompass Health posted earnings per share of $0.99 in the same quarter last year, which would indicate a negative year-over-year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Wednesday, July 24th.

According to Zacks, analysts expect that Encompass Health will report full year earnings of $3.80 per share for the current financial year, with EPS estimates ranging from $3.75 to $3.88. For the next fiscal year, analysts forecast that the firm will report earnings of $3.85 per share, with EPS estimates ranging from $3.57 to $4.00. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research analysts that cover Encompass Health.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, April 25th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.15. Encompass Health had a net margin of 7.14% and a return on equity of 23.82%. The company had revenue of $1.12 billion during the quarter, compared to analysts’ expectations of $1.11 billion.

Several equities analysts have recently commented on the stock. ValuEngine lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. Barclays upgraded shares of Encompass Health from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $68.00 to $70.00 in a report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $79.50.

NYSE:EHC opened at $60.95 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 1.71. The stock has a market capitalization of $6.01 billion, a price-to-earnings ratio of 16.79, a PEG ratio of 2.04 and a beta of 0.79. Encompass Health has a 1-year low of $56.74 and a 1-year high of $82.46.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Friday, June 28th. Encompass Health’s dividend payout ratio is presently 29.75%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Article: What is Cost of Goods Sold (COGS)?

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.